Tarik Skubal’s Elbow Procedure and the Detroit Tigers’ Trade-Deadline Decision

Detroit’s left-handed starter Tarik Skubal underwent a third elbow operation in May, this time involving a novel arthroscopic technique that his agent, Scott Boras, has dubbed the “Skubal scope.” Boras asserts that the procedure extracted a small, non-ligamentous particle and that the minimally invasive nature of the needle-size intervention could halve the typical recovery period. If the claim holds, Skubal could rejoin the rotation by the All-Star break, giving him roughly two months to demonstrate his pre-injury performance before the July 31 trade deadline.

FanSided

Skubal, described in the source material as a two-time Cy Young award winner, is set to become a free agent after the season. The Tigers have been labeled an “afterthought” in his looming free-agency market, yet the team may still seek a “Juan Soto-like” return, a benchmark that would require a substantial prospect package. The typical recovery window for the type of elbow surgery Skubal received is cited as two to three months, prompting many clubs to hesitate before committing significant resources to an ace still on the mend.

FanSided

Boras explained the procedure on the *Baseball Tonight* podcast, noting the particle’s size and the surgeon’s confidence in a faster return. ESPN reporter Kiley McDaniel highlighted a scenario in which the Tigers could retain Skubal on a short-term contract with opt-out clauses, a possibility she said has risen since the injury. Industry chatter suggests GM Scott Harris may only consider a trade if a return comparable to a top-tier hitter materializes.

FanSided

Analysts point out that the “halved” recovery claim conflicts with the standard two-to-three-month timeline for similar surgeries. Moreover, MLB teams are described as “rightly weary” of acquiring a pitcher at a premium cost while his health remains uncertain. The Tigers could instead secure a compensatory draft pick if Skubal departs in free agency, a return that may outweigh a modest trade package.

FanSided

• Recovery Time: Boras predicts a 50 % reduction; other sources cite a 2-3 month norm.

FanSided

• Market Valuation: No concrete offers have been reported, leaving the Tigers’ trade leverage ambiguous.

FanSided

• Timeline to Return: No definitive date beyond “by the All-Star break” has been confirmed.

FanSided

• “It was kind of a lima-bean-sized particle that was nowhere near a ligament or anything,” — Scott Boras

FanSided

• “After Dr. ElAttrache got the MRI, he told me, ‘I have a new procedure that I think is something that we can discuss that will really, really limit the time that Tarik would be off versus a normal arthroscope.’ He essentially went in and was able to see the particle, extract it, and in effect, the consequence was that it was almost like Tarik had had an injection, because the needle’s so small.” — Scott Boras

FanSided

• “Word around the industry has long been that Harris will seek a Juan Soto-like return for Skubal, however unlikely that may be for an ace coming off an elbow procedure.” — Source (Fansided)

FanSided

• “Sources agreed, though, that the chances that Skubal will go back to the Detroit Tigers on a shorter-term deal with opt-outs is much higher than it was before this injury," McDaniel wrote.” — Kiley McDaniel, ESPN

FanSided

• “If Detroit struggles to find a suitor for Skubal that will meet their enormous asking price, then hanging onto him could be in their best interest.” — Source (Fansided)

FanSided

The Tigers face three primary paths: (1) trade Skubal for a high-value prospect package, (2) retain him on a short-term contract with opt-outs while he works toward a mid-season return, or (3) allow him to reach free agency and collect a compensatory draft pick. The ultimate decision hinges on the veracity of the accelerated recovery claim, the emergence of credible trade offers, and the organization’s assessment of roster flexibility heading into the final months of the season.

FanSided